Delivery Order SPE2DB22D1106-SPE2DB25FFAQ1
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,836.26 to AmerisourceBergen Drug Corp for the supply of Tafinlar 50 mg capsules (120 count) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by August 20, 2025. AmerisourceBergen will perform this work from its corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,792.82, is for the delivery of 4,568,201,792 units of the medication Tafinlar 75 mg capsules. The contract has an ultimate completion date of June 2, 2025 and was awarded on May 9, 2025. The contract is not set aside and is open to full and open competition....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,792.82 firm fixed-price contract is for the supply of 4,568,120,296 units of the prescription medication Tafinlar 75 mg capsule. The contract has a period of performance through May 23, 2025. This award is not associated with a set-aside program and is part of a larger $999,999,999.00 Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 120 capsules of Tafinlar 75 mg, a chemotherapy medication used primarily for melanoma treatment. This firm fixed-price delivery order, valued at $8,896.41, was awarded on July 21, 2025, with an ultimate completion date of August 11, 2025. The contract was not set aside and represents a competitively awarded transaction under the company's existing contract vehicle. Performance will occur at...
- The Defense Logistics Agency awarded a $7,940.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 capsules of Tafinlar, a cancer treatment medication, to be delivered to a facility in Conshohocken, Pennsylvania by September 11, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will fulfill this order from its corporate headquarters using its extensive distribution network to rapidly deliver this critical...
- This is a $8,139.33 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 120 units of the cancer medication Tafinlar 75 mg capsules. The contract has an ultimate completion date of August 15, 2024 and does not have a set-aside designation. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication TAFINLAR 75 MG CAPSULE 120S. The contract has a ceiling value of $8,896.41 and is a firm fixed-price delivery order with a completion date of June 9, 2025. The contract is not set-aside and was awarded on May 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency Troop Support Medical awarded a $37,000 delivery order to Amerisourcebergen Drug Corporation for 120 capsules of the cancer drug Tafinlar. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania location to support DLA medical programs. The firm fixed price order has a period of performance from July 10-31, 2023. No set aside designation or subcontractors were identified. DLA manages the global supply chain for the Department...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $14,281.08 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 120 capsules of Tafinlar, a prescription medication used to treat certain types of skin cancer and lung cancer, to locations within the Conshohocken, Pennsylvania area. The order is funded by the Defense Logistics Agency and supports the agency's medical supply needs. Amerisourcebergen, a subsidiary of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $8,139.33 Firm Fixed Price delivery order is for the provision of 120 count bottles of the prescription drug Tafinlar 75 mg capsules. The award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAQ1Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Tafinlar 50 mg capsules (120-count units) under a firm fixed-price contract valued at $27,672.52. This delivery order is expected to be completed by August 20, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen Drug Corp's demonstrated capability to meet federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion contract vehicle (designated SPE2DX) running through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications, vaccines, and medical supplies to support military and veteran healthcare systems worldwide. The Tafinlar order represents one of numerous pharmaceutical deliveries the company fulfills for the DLA Medical Supply Chain, supporting the Defense Health Agency and other government healthcare systems through this flexible and extensive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.7k | 7/30/25 |